Life ScienceCompany
Smith & Nephew - TransCyte Product Line Ownership
Who owns Smith & Nephew - TransCyte Product Line?
Smith & Nephew - TransCyte Product Line is owned by Shire Regenerative Medicine. It was acquired on May 31, 2006.
Smith & Nephew - TransCyte Product Line Business Overview
Where is Smith & Nephew - TransCyte Product Line headquartered?
Smith & Nephew - TransCyte Product Line is headquartered in United Kingdom.
What sector is Smith & Nephew - TransCyte Product Line in?
Smith & Nephew - TransCyte Product Line is a life science company.
Life Science M&A Summary in 2006
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2006. The largest life science acquisition in 2006 was Guidant - which was acquired by Boston Scientific for $24.6B.
Join Mergr to view all 120 acquisitions of life science companies in 2006, including 22 acquisitions by private equity firms, and 98 by strategics.